Vimarsana
Biggest News Aggregation in the World

Page 4 - Bunion Correction News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bunion Correction. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bunion Correction Today - Breaking & Trending Today

Treace Medical Concepts Appoints New Directors - Vimarsana News

Treace Medical Concepts Appoints New Directors

PONTE VEDRA, Fla., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology...

Treace Highlights New Product Innovations at the 2022 AOFAS Scientific Conference - Vimarsana News

Treace Highlights New Product Innovations at the 2022 AOFAS Scientific Conference

PONTE VEDRA, Fla., Sept. 13, 2022 -- Treace Medical Concepts, Inc. , a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus , announces it will...

Treace Medical Concepts, Inc. (TMCI) Q4 2021 Earnings Call Transcript - Vimarsana News

Treace Medical Concepts, Inc. (TMCI) Q4 2021 Earnings Call Transcript

TMCI earnings call for the period ending December 31, 2021.

Source: fool.com
Treace Medical Concepts : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K - Vimarsana News

Treace Medical Concepts : Reports Fourth Quarter and Full Year 2021 Financial Results - Form 8-K

Treace Medical Concepts Reports Fourth Quarter and Full Year 2021 Financial Results PONTE VEDRA, Fla. - March 3, 2022-Treace Medical Concepts, Inc. , a medical technology... | March 3, 2022

Treace Medical Concepts Reports First Quarter 2021 Financial Results - Vimarsana News

Treace Medical Concepts Reports First Quarter 2021 Financial Results

Message : Required fields PONTE VEDRA, Fla., May 25, 2021 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a commercial-stage orthopaedic medical device company driving a paradigm shift in the surgical treatment of Hallux Valgus (commonly known as bunions), today reported financial results for the first quarter ended March 31, 2021. Recent Highlights: Revenue of $18.7 million, a 66% increase over the same period last year Gross margin of 82.2%, an increase of 340 basis points from the same period last year Completed initial public offer...